Pharmacovigilance – Products

Despite possessing numerous advantageous pharmacological properties, the comprehensive annotation of saponins remains challenging. Download this app note to discover how a structure-based mass spectrometry workflow can be used.

A multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222 has begun.

Enterprise Therapeutics has announced it has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD002.

Byondis B.V. has announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate, SYD1875.

AMSBIO is offering a comprehensive range of end-to-end services for exosome purification, characterization, and engineering.

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced an update to its previously announced partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines.

osteolabs GmbH has announced further validation and clinical evidence for the use of OsteoTest for the early detection of bone loss.

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.

ZEISS has introduced a new light sheet fluorescence microscope that allows multiview imaging of both living and cleared specimens.